2024-12-10 – Press Releases – www.prnewswire.com
Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company’s ongoing Phase 1 trial in patients with Huntington’s Disease Volumetric MRI measurement is also approved as exploratory study endpoint BOSTON, Dec. 10, 2024 /PRNewswire/ — Skyhawk…